These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6664939)

  • 1. Studies on the role of catecholamines in the action of fibrinopeptides A and B in the circulatory system of rats.
    Antecka-Genadiew E; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(5):367-76. PubMed ID: 6664939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of fibrinopeptides A and B on the circulatory action of dopamine.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):285-92. PubMed ID: 6664936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some pharmacological and biochemical effects of fibrinopeptides A and B in the circulatory system of rats.
    Antecka-Genadiew E; Buczko W; Stasiak A; Maciejewski A; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(5):359-66. PubMed ID: 6664938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of fibrinopeptides A and B on the central dopaminergic system of rats pretreated with indomethacin.
    Swiderska D; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1986; 38(1):21-8. PubMed ID: 3763484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of products of degradation of fibrinogen A and B on the arterial blood pressure in the rat.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):279-83. PubMed ID: 6664935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further studies on the effect of fibrinopeptides A and B on the central nervous system.
    Bernacka I; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):407-14. PubMed ID: 7329866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of prostaglandins E2 and F2 alpha in the action of fibrinopeptides A and B on the central dopaminergic system.
    Swiderska D; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1986; 38(1):29-39. PubMed ID: 3463941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of bovine fibrinopeptides on the central action of chlorpromazine and amphetamine in rats.
    Buczko W
    Acta Neurobiol Exp (Wars); 1976; 36(4):447-54. PubMed ID: 983820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sympathoadrenal system mediates the blood pressure and cardiac effects of human coagulation factor XII-related "new pressor protein".
    Mavrogiannis L; Trambakoulos DM; Boomsma F; Osmond DH
    Can J Cardiol; 2002 Oct; 18(10):1077-86. PubMed ID: 12420043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fibrinopeptides A and B on human and rat platelet aggregation in vitro.
    Moore PK; Hussaini I; Bhardwaj R
    Eur J Pharmacol; 1988 Aug; 153(2-3):231-8. PubMed ID: 3053211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and B.
    Kessler CM; Bell WR
    J Lab Clin Med; 1979 May; 93(5):758-67. PubMed ID: 429874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
    Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
    J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of antiinflammatory activity of fibrinogen and fibrinopeptides in rats.
    Ruhenstroth-Bauer G; Scherer R; Hornberger M; Tongendorff G
    Inflammation; 1981 Dec; 5(4):343-51. PubMed ID: 7327698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action.
    Lenke D; Gries J; Kretzschmar R
    Arzneimittelforschung; 1981; 31(9a):1558-65. PubMed ID: 7197970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurogenic components in cardiovascular reactivity of chronically lead-exposed rats.
    Carmignani M; Boscolo P; Marchetti P; Iannaccone A
    Dev Toxicol Environ Sci; 1980; 8():595-8. PubMed ID: 7308067
    [No Abstract]   [Full Text] [Related]  

  • 18. GABAB-ergic stimulation in hypothalamic pressor area induces larger sympathetic and cardiovascular depression in spontaneously hypertensive rats.
    Takenaka K; Sasaki S; Uchida A; Fujita H; Nakamura K; Ichida T; Itoh H; Nakata T; Takeda K; Nakagawa M
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):964-72. PubMed ID: 8896648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human coagulation factor XII-related "new pressor protein": role of PACAP in its cardiovascular and sympathoadrenal effects.
    Simos D; Boomsma F; Osmond DH
    Can J Cardiol; 2002 Oct; 18(10):1093-103. PubMed ID: 12420044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central effects of D-Ala2-met-enkephalinamide on the blood pressure of rats after central chemical sympathectomy or serotoninectomy.
    Brus R; Szkilnik R; Krzeminski T; Juraszczyk Z; Kurcok A; Herman ZS
    Biomed Biochim Acta; 1985; 44(5):779-83. PubMed ID: 4062924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.